Thierry Walzer

Inserm U1111, UMR5308, Claude Bernard University Lyon 1
Lyon, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 119 publications

A novel STAT4 gain-of-function variant defines a monogenic form of juvenile-onset systemic lupus erythematosus.

A novel STAT4 gain-of-function variant defines a monogenic form of juvenile-onset systemic lupus erythematosus.

Journal: Annals of the rheumatic diseases
Published: February 21, 2026

Dual inhibition of mTOR and calcineurin pathways mitigates missing self-induced NK cell-mediated microvascular rejection.

Dual inhibition of mTOR and calcineurin pathways mitigates missing self-induced NK cell-mediated microvascular rejection.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 11, 2026

Exome sequencing enables molecular diagnosis in 10% of early-onset or familial systemic lupus erythematosus cases.

Exome sequencing enables molecular diagnosis in 10% of early-onset or familial systemic lupus erythematosus cases.

Journal: EBioMedicine
Published: October 07, 2025

Single-cell analysis identifies CPT1a-associated metabolic remodeling in human NK cells during COVID-19.

Single-cell analysis identifies CPT1a-associated metabolic remodeling in human NK cells during COVID-19.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 23, 2025

Interleukins 15 and 18 synergistically prime the antitumor function of natural killer cells through noncanonical activation of mTORC1.

Interleukins 15 and 18 synergistically prime the antitumor function of natural killer cells through noncanonical activation of mTORC1.

Journal: Science signaling
Published: September 16, 2025

Immunological and Clinical Markers of Post-acute Sequelae of COVID-19: Insights from Mild and Severe Cases 6 Months Post-infection.

Immunological and Clinical Markers of Post-acute Sequelae of COVID-19: Insights from Mild and Severe Cases 6 Months Post-infection.

Journal: European journal of immunology
Published: March 17, 2025

IRF2 deficiency disrupts pyroptosis, NK cell interferon-γ production and resistance to Francisella.

IRF2 deficiency disrupts pyroptosis, NK cell interferon-γ production and resistance to Francisella.

Journal: EMBO reports
Published: February 25, 2025

Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer.

Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer.

Journal: Nature reviews. Drug discovery
Published: November 06, 2024

Tumor-induced natural killer cell dysfunction is a rapid and reversible process uncoupled from the expression of immune checkpoints.

Tumor-induced natural killer cell dysfunction is a rapid and reversible process uncoupled from the expression of immune checkpoints.

Journal: Science advances
Published: August 28, 2024

BA.1 breakthrough infection elicits distinct antibody and memory B cell responses in vaccinated-only versus hybrid immunity individuals.

BA.1 breakthrough infection elicits distinct antibody and memory B cell responses in vaccinated-only versus hybrid immunity individuals.

Journal: iScience
Published: July 22, 2024

Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders.

Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders.

Journal: The journal of allergy and clinical immunology. Global
Published: April 19, 2024

NK Cell Immaturity and NKp30 Expression Positively Correlate with Clinical Outcome in Multiple Myeloma Patients from the IFM2009 Clinical Trial.

NK Cell Immaturity and NKp30 Expression Positively Correlate with Clinical Outcome in Multiple Myeloma Patients from the IFM2009 Clinical Trial.

Journal: European journal of immunology
Published: April 15, 2024
Showing 1-12 of 119

Last Updated: 09/26/2026